tagoor chemicals private limitedenvironmentclearance.nic.in/writereaddata/online/tor/07...raju is...

PRE - FEASIBILITY REPORT

For

EXPANSION OF EXISTING BULK DRUG &

INTERMEDIATES MANUFACTURING UNIT

at

Survey No: 32, Tupakulagudem (Village), Tallapudi

(Mandal), West Godavari (Dist.), Andhra Pradesh

By

TAGOOR CHEMICALS PRIVATE LIMITED (Formerly known as Vensar Laboratories Pvt Ltd)

Office address:

Duplex No: 29, Lakshmi Gayatri Enclave, Aditya Nagar, KPHB,

Kukatpally, Hyderabad

November - 2017

Contents

S. No. Description Page no.

1.0 Executive Summary 1

2.0 Introduction of the Proposed Project 2

2.1 Project Proponent 2

2.2 Brief description of the project 3

2.3 Need for the project and its importance to the country and or

region 3-4

2.4 Demand-Supply Gap. 4-5

2.5 Employment Generation(Direct and Indirect) due to the project

5

3.0 Project description 5

3.1 Product and Production Capacity 8

3.2 Raw materials required and Quantities 11

3.3 Manufacturing Process 11

3.4 Resource – Utilize and Recycling 12

3.4.1 Water 12

3.4.2 Power Requirement 12

3.4.3 Fuel Requirement 12

3.5 Quantity of wastes generated 12

3.5.1 Waste Water Generation and utilization 12 - 13

3.5.2 Solid waste generation and Disposal 13

3.6 Schematic representations of the feasibility drawing which give information of EIA purpose

14

4.0 Site Analysis 15

4.1 Connectivity 15

4.2 Land Form, Land use and Land ownership. 15

4.3 Existing Infrastructure 15

4.4 Soil classification 15

4.5 Climatic data from secondary sources 15

4.6 Social Infrastructure available 16

5.0 Planning in brief 16

6.0 Proposed infrastructure 16

6.1 Industrial Area 16

6.2 Residential Area 16

6.3 Green Belt 16

6.4 Social Infrastructure 16 - 17

6.5 Water management 17

6.6 Sewerage System 17

6.7 Industrial Waste Management 17

7.0 Rehabilitation and Resettlement (R&R) Plan 17

8.0 Project Schedule and Cost estimate 17

9.0 Analysis of project 17

LIST OF TABLES

Table No Description Page no.

3.1 Proposed Products and Existing Products and their Production Capacities

8 - 10

3.2 List of By-Products 10 - 11

3.3 Water Requirement Details 13

3.4 Wastewater generation and Treatment Method 13

3.5 Solid and hazardous waste generation and Disposal 13 -14

LIST OF FIGURES

Figure No Description Page no.

3.1 Location Map 6

3.2 Google Earth Map Showing Tagoor Chemicals Private

Limited

7

LIST OF FLOW CHART

Flow Chart No

Description Page no.

3.1 Generalized Flow Chart for Bulk Drug Manufacturing 11

Tagoor Chemicals Private Limited Pre Feasibility Report

Page 1

1.0 EXECUTIVE SUMMARY

Tagoor Chemicals Private Limited (Formerly known as Vensab Laboratories Pvt

Ltd) is a partnership firm and it is registered office at Duplex No: 29, Lakshmi Gayatri

Enclave, Aditya Nagar, KPHB, Kukatpally, Hyderabad Telangana State.

S. No Parameter Description

1 Project Location Survey No: 32, Tupakulagudem (V) Tallapudi

(M), West Godavari (Dist.), Andhra Pradesh

2 Category of Project as per EIA Notification & Amendments

5(f) “A”

3 Project cost 39 Crores

4 Plot area 10.35 Acres (41885 Sq.m)

5 Proposed Products Proposed Products List is mentioned in section

3.1

Resources

6 (I)Electricity

Requirement 800 KVA

7 Source of electricity Andhra Pradesh Southern Power Distribution

Company Limited (APSPDCL)

D. G. Sets

Existing: 250 KVA (Continued)

Proposed: 500 KVA

(II)Water consumption 190.00 KL/day

8 Source of water Ground Water

Waste water generation 80.00 KL/ day

(III)Boiler

Existing: 6.0 TPH Coal fired/ Agro waste fired

Boiler, 2,00,000 kcal/hr. Thermo pack Boiler

(Continued);

Proposed: 4.0 TPH Coal fired/ Agro waste fired Boiler

9 (IV)Fuel Coal Requirement – 33.00 TPD for proposed & Existing boilers and Thermo pack Boiler

10 Mode of disposal Zero Liquid Discharge System

11 Solid waste generation Mentioned in Para 3.5.2 of report

12 Nearest Highway National Highway NH - 16: 26 KMs (SE) (Rajahmundry – Anakapalle)

13 Nearest Railway Station Kovvuru Railway station – 22.0 KMs (SE)

14 Nearest Airport Rajahmundry Airport – 24.00 KMs (ESE)


Page 2

2.0 INTRODUCTION OF THE PROJECT

The objective of this pre- feasibility study is to provide information on proposed to

Expansion of Existing Bulk Drug & Intermediate manufacturing unit of Tagoor

Chemicals Private Limited (Formerly known as Vensar Laboratories Pvt Ltd)

located at Sy No. 32, Tupakulagudem Village, Tallapudi Mandal, West Godavari

District, Andhra Pradesh

2.1 Project Proponent

Mr. Penmetsa Subramanyam Raju, Managing partner of the company is young

and energetic personality with vast experience in pharmaceutical industry

Mr. Subramanya Raju has work experience of more than 18 years in bulk drugs

industry. He has worked in senior position as Director-manufacturing in Vasudha

group of industries and helped to emerge as one of the leading group in bulk drug

industry. During his tenure in Vasudha Pharma Chem Limited, he had managed 3

units situated in jeedimetla, kazipally, and Visakhapatnam looking after production,

research and development, packing, dispatch of the finished intermediates and APIs

at right time, conforming to the specifications. Added to this, he is actively involved in

discussing with the customers for extracting business by increasing the yields and

reducing production cost to meet the demand of the customers. He has visited many

countries in Europe & Asia for exhibiting the bulk drug products. Mr. Subramanyam

Raju is also Managing Partner of Sri Venkateswara Industries which manufactures

the intermediates & bulk drugs, situated in Hyderabad. Considering his skills and

abilities, M/s Shree Jaya Laboratories Pvt Ltd., have offered him the post of Director

during February 2012 and he assumed charge of the Director during February 2012

and has taken charge as Chairman during April 2013 looking after the entire

production, research and development activities of the organization. He has

improved the turnover of the company from 28 crores to 120 crores within a short

span of one year.

Mr. Subramanyam Raju is experienced in manufacturing, process development,

project management, scale up to operations, quality systems and the aqua culturing

technically.


Page 3

Mr. Subramanyam Raju was also awarded Hon. Doctorate by the international

university in Colombo during November 2013. He has also acquired more than

20acres of land in west Godavari district of Tallapudi Mandal for establishment of

Vensar and Vensub laboratories for manufacturing APIs. All the relevant licenses for

commencement of the units were obtained and the land is made ready for

construction works.

Dr. Pericherla Kasiviswanadharaju, the partner of the company is technically

qualified person, having rich experience in organic synthesis. He recently finished his

Ph.D from prestigious institute BITS Pilani, Rajasthan and his technical background

is an additional asset to the industry. Presently, he is involved in purchase,

marketing and research and development departments.

2.2 Brief description of the project.

Tagoor Chemicals Private Limited (Formerly known as Vensar Laboratories Pvt

Ltd) is proposed to expansion of Existing Bulk Drug & Intermediate manufacturing

unit at Survey No: 32, Tupakulagudem (V) Tallapudi (M), West Godavari (Dist.),

Andhra Pradesh.

2.3 Need for the project and its importance to the country and region


Ltd) is proposed to expansion of existing Bulk Drug & Intermediate manufacturing

unit at Survey No: 32, Tupakulagudem (V) Tallapudi (M), West Godavari (Dist.),

Andhra Pradesh.

Availability of the well-connected road and railway network for easy transportation

of the construction equipments and materials, Raw materials and finished

products.

Easy availability of skilled and unskilled labor for construction of Plant and its

operation.

The Indian pharmaceutical industry currently tops the chart amongst India's science-

based industries with wide ranging capabilities in the complex field of drug

manufacture and technology. A highly organized sector, the Indian pharmaceutical

industry is estimated to be worth $ 4.5 billion, growing at about 8 to 9 percent

annually. It ranks very high amongst all the third world countries, in terms of


Page 4

technology, quality and the vast range of medicines that are manufactured. It ranges

from simple headache pills to sophisticated antibiotics and complex cardiac

compounds; almost every type of medicine is now made in the Indian

pharmaceutical industry.

The Indian pharmaceutical sector is highly fragmented with more than 20,000

registered units. It has expanded drastically in the last two decades. The

Pharmaceutical and Chemical industry in India is an extremely fragmented market

with severe price competition and government price control The Pharmaceutical

industry in India meets around 70% of the country's demand for bulk drugs, drug

intermediates, pharmaceutical formulations, chemicals, tablets, capsules, orals, and

injectibles. There are approximately 250 large units and about 8000 Small Scale

Units, which form the core of the pharmaceutical industry in India (including 5 Central

Public Sector Units).

The Indian pharma industry, which is expected to grow over 16 per cent per annum

between 2017 and 2020, will outperform the global pharma industry, which is set to

grow at an annual rate of 5 per cent between the same period!. The market is

expected to grow to US$ 55 billion by 2020, thereby emerging as the sixth largest

pharmaceutical market globally by absolute size, as stated Indian Ambassador to the

US. Branded generics dominate the pharmaceuticals market, constituting nearly 80

per cent of the market share (in terms of revenues).

India has also maintained its lead over China in pharmaceutical exports with a year-

on-year growth of 11.44 per cent to US$ 12.91 billion in FY 2015-16, according to

data from the Ministry of Commerce and Industry. Imports of pharmaceutical

products rose marginally by 0.80 per cent year-on-year to US$ 1,641.15 million.

Overall drug approvals given by the US Food and Drug Administration (USFDA) to

Indian companies have nearly doubled to 201 in FY 2015-16 from 109 in FY 2014-

15. The country accounts for around 30 per cent (by volume) and about 10 per cent

(value) in the US$ 70-80 billion US generics market.

2.4 Demand-Supply Gap.

There is a quite considerable gap between supply and demand for, fine chemicals,

bulk drugs and intermediates. Very few players are in the market who can offer

continuous supply. The company wants to bridge this gap between demand and

supply by expanding the production capacity and thereby, making good business.


Page 5

Company's marketing edge comes from its direct and close contact with the

customers. Their products are major strength of their customers. Each stage of their

product is been monitored /checked for their quality to ensure quality product

reaches their customer. They plan to launch new products every year to satisfy the

need of their customers as per the market demand.

2.5 Employment Generation (Direct and Indirect) due to the project

Approximate employment generation due to proposed unit is 115. Apart from this

there will be significant non estimated employment generation at the supplier firms

and service industry providing services to the company. Company shall be giving

preference to people from economically weaker sections for employment in various

semi-skilled/unskilled jobs thereby contributing to their upliftment.

3.0 Project Description


Ltd) is proposing the Expansion of existing Bulk Drug and Intermediates

Manufacturing Unit with production capacity of 130.00 TPM

The Location map is shown at Figure - 3.1 and Google earth map showing Tagoor

Chemicals Private Limited (Formerly known as Vensar Laboratories Pvt Ltd) plant is

shown at Figure - 3.2.

The site central GPS - coordinates are

Latitude: 17009’27.26” North

Longitude: 81035’32.23” East

The project site does not offer any negative impact on the local area, but rather it has

a positive impact on socio economic conditions of the habitants around it because of

employment to locals.

The Tagoor Chemicals Private Limited (Formerly known as Vensar Laboratories Pvt

Ltd) is 26 kms away from National Highway NH – 16 and 22 kms from

Kovvur Railway station.


Page 6

FIGURE 3.1: LOCATION MAP

Project Site


Page 7

FIGURE 3.2: GOOGLE EARTH MAP SHOWING TAGOOR CHEMICALS PRIVATE LIMITED


Page 8

3.1 Proposed Products and Existing Products and their Production Capacities


Ltd) is proposing to Expansion of existing Bulk Drug and Intermediates

Manufacturing Unit Capacity of 130.00 TPM and the list of proposed products and

Existing Products are shown in Table 3.1 & 3.2.

Table 3.1: Proposed Products and Quantities

S.No. Product Name

Production Capacity

Kg/ Month

CAS No. Therapeutic

category

1 Amitriptyline 5000.00 549-18-8 Antidepressant

2 Atrovastatin Calcium 5000.00 134523-03-8 Hypercholesterolemia

3 Bupropion 5000.00 34841-39-9 Anti depressant

4 Clopidogrelbisulfate 5000.00 135046-48-9 Antithrombotic

5 Cyclobenzaprine HCl 5000.00 6202-23-9 Muscle relaxant

6 Cyproheptadine HCl 5000.00 41354-29-4 Anti allergic

7 Desloratadine 5000.00 100649-74-8 Antihistamine

8 Domperidone 20000.00 99497-03-7 Anti emetic

9 Domperidone maleate 2000.00 99497-03-7 Anti emetic

10 Donepezil HCl 1000.00 12004-70-3 Alzheimer’s disease

11 Ebastine 5000.00 90729-43-4 Anti allergic

12 Esomeprazole Sodium 3000.00 161796-78-7 Anti ulcerative

13 Esomeprazole Magnesium trihydrate

3000.00 217087-09-7 Anti ulcerative

14 Fexofenadine Hydrochloride

5000.00 143439-40-8 Anti histamine

15 Haloperidol 2000.00 52-86-8 Antipsychotic

16 Itopride Hydrochloride 2000.00 122892-31-3 Antispasmodics

17 Itraconazole 10000.00 84625-61-6 Antifungal

18 Ketrolac Tromethane 2000.00 74103-07-4 Anti Inflammatory

19 Lansoprazole 10000.00 103577-45-3 Ant ulcerative

20 Loperamide Hydrochloride 10000.00 34552-83-5 Anti diarrhea agent

21 Losartan Potassium 2000.00 124750-99-8 Anti Hypertensive

22 Nebivolol HCl 2000.00 99200-09-6 Anti Hypertensive

23 Nortriptyline HCl 2000.00 894-71-3 Anti depressant

24 Omeprazole 40000.00 95510-70-6 Ant ulcerative

25 Omeprazole Sodium 2000.00 95510-70-6 Ant ulcerative

26 Omeprazole Magnesium Dihydrate

2000.00 95382-33-5 Ant ulcerative

27 Oxatomide 1000.00 60607-34-3 Antihistamine


Page 9

28 Pantoprazole Sodium Sesqui Hydrate 10000.00

164579-32-2 Ant ulcerative

29 Pimozide 2000.00 2062-78-4 Antipsychotic

30 Pregabalin 2000.00 148553-50-8 Epileptic

31 Quetiapine Hemifumarate 2000.00 111974-72-2 Antipsychotic

32 Rabeprazole Sodium 10000.00 117976-90-6 Ant ulcerative

33 Rupatadine fumarate 2000.00 182349-12-8 Antihistamine

34 Telmisartan 2000.00 144701-48-4 Anti Hypertensive

35 Terbinafine hydrochloride 10000.00 78628-80-5 Anti fungal

36 Valsartan 2000.00 137862-59-4 Anti Hypertensive

37 1-Benzy-4-piperidone 5000.00 3612-20-2 Drug Intermediate

38 1-Benzyl-4-chloropiperidine

5000.00 67848-71-9 Drug Intermediate

39 1-Benzylpiperidin-4-ol 5000.00 4727-72-4 Drug Intermediate

40 1-Methylpiperidin-4-amine 5000.00 41838-46-4 Drug Intermediate

41 4-Aminopiperidine 5000.00 13035-19-3 Drug Intermediate

42 4-Hydroxy piperidine 5000.00 5382-16-1 Drug Intermediate

43 4-Phenylpiperidine 1000.00 771-99-3 Drug Intermediate

44 4-piperidinopiperidine 1000.00 4897-50-1 Drug Intermediate

45 N-tert-Butoxycarbonyl-4-hydroxy piperidine

5000.00 109384-19-2 Drug Intermediate

Total ( Worst Combination of any 10 Products at any given point of time) 130000.00

Note:

The above Listed Products, we will manufacture either Finished Product or any

Intermediate stage of finished Product as per given quantity by not increasing the

production capacity of 130 MT/Month.

Existing Products

S. No

Product Name Therapeutic category /

Application Quantity in MT/Month

Quantity in Kgs/Day

1 Carvedilol Cardiovascular 5 166.67

2 Citalopram Hydro Bromide

Antidepressant 2 66.67

3 Ketrolac tromethamine Anti-inflammatory 5 166.67

4 Ramipril Cardiovascular 5 166.67

5 Sertraline Hydrochloride

Antidepressant 5 166.67

6 Terbinafine Antifungal 4 133.33


Page 10

S. No

Product Name Therapeutic category /

Application Quantity in MT/Month

Quantity in Kgs/Day

Hydrochloride

7 Tramadol Hydrochloride

Analgesic 5 166.67

Total (Worst combination of any two products on campaign basis only)

10 333.33

Table 3.2: By Products

S. No. Name of Product Name of the By-

Product Quantity in

Kg/Day

1 Clopidogrel Bisulphate

Ammonium Sulphate 101.39 Omeprazole Magnesium Dihydrate

2 Cyclobenzaprine HCl

Sodium Bromide 174.62 Itrazconazole

3

Cyclobenzaprine HCl

Magnesium Chloride 295.12 Cyproheptadine HCl

Desloratadine

Pantoprazole Sodium Sesquihydrate

4

Desloratadine

Potassium Chloride 374.60 Ebastine

Terbinafine HCl

5 Desloratadine Aluminum Chloride 54.26

6

Domperidone Maleate

Sodium acetate 366.60 Pantoprazole Sodium Sesquihydrate

Rabeprazole Sodium

7 Itopride HCl

TEA HCl 127.86 Itraconazole

8

Telmisartan

Potassium Bromide 172.58 Valsartan

Itraconazole

9 Itraconazole Sodium Benzoate 72.26

10 Losartan Potassium Trityl alcohol 104.16

11 Pregabalin Potassium acetate 96.38

12 Ebastine Hydrogen Chloride 149.17

Note: The By-Products will be produced according to the combination of required

products manufacturing.


Page 11

3.2 Raw materials required and Quantities

All the raw materials required for manufacturing of above products will be sourced

from local market.

3.3 Manufacturing Process

The manufacturing process of bulk drugs and Intermediates consists of chemical

synthesis extending to stages of processing involving different type of chemical

reactions. The generalized Flow chart for bulk drug manufacturing is shown in Flow

chart 3.1.

Flow Chart 3.1: Generalized Flow Chart for Bulk Drug Manufacturing

3.4 Resource – Utilize & Recycling

3.4.1 Water

Water requirement of the project for domestic and industrial activity during operation

phase will be 190.00 KLD. The water requirement will be met through ground water

sources. The detailed water requirement shown in below Table 3.3


Page 12

Table 3.3: WATER REQUIREMENT DETAILS

S.No Purpose Water consumption

In KLD

1 Process 36.00

2 Washings 5.00

3 Boiler make up 58.50

4 Cooling towers make up 72.50

5 Scrubbing system 8.00

6 Domestic 5.00

7 Gardening 5.00 Total 190.00

3.4.2 Power Requirement

Power requirement of proposed project will be made available through Andhra

Pradesh Southern Power Distribution Company Limited (APSPDCL). The total

power requirement for the unit is 800 KVA respectively

D.G. sets of Existing 250 KVA (Continued) and 500 KVA is proposed to install to

meet the emergency power requirement of the plant.

3.4.3 Fuel Requirement

The existing 6.0 TPH Coal fired/ Agro waste fired Boiler, 2,00,000 kcal/hr. Thermo

pack Boiler (Continued) proposed to install 4.0 TPH Coal fired/ Agro waste fired

Boiler and total fuel requirement of coal will be around 16.00 MT /Day and it will be

procured from local sources.

3.5 Quantity of wastes to be generated

3.5.1 Waste Water Generation and utilization

Total effluent will generate in the project is 80.00 KLD. The treated water will be

reused for plant operations.

The HTDS waste water from Process after neutralization taken for treatment in

stripper followed by MEE and ATFD, vapor condensate collected and transferred to

Biological Treatment. LTDS waste water including domestic sewage, floor Washes,

Utilities waste water taken along with Vapour Condensate from MEE & ATFD for

Biological Treatment. Treated effluent from BTP sent to RO, RO permeate collected


Page 13

and RO rejects are sent to MEE followed by ATFD for evaporation and separation of

salts. Evaporation salts collected and sent to TSDF. MEE & ATFD vapour

condensates collected & reused along with RO permeate in plant operations.

Table 3.4: Waste water generation and Treatment Method

Unit HTDS KLD

LTDS KLD

Effluent Generation in

KLD Treatment Method

Process 29.50 14.50 44.00 HTDS effluent sent to ETP with MEE System LTDS effluents treated in ETP – RO Plant / RO Rejects to MEE System and RO permeate to reuse, Condensate from MEE to reuse and MEE residue to ATFD.

Washings 0.00 5.00 5.00

Boiler Blow down

0.00 8.50 8.50

Cooling towers Blow down

0.00 10.50 10.50

Scrubbing system

8.00 0.00 8.00

Domestic 0.00 4.00 4.00

Septic tank followed by soak pit

Total 37.50 42.50 80.00

3.5.2 Solid and Hazardous waste generation and Disposal

The types of Solid and Hazardous wastes generated from the project, method of

disposal is shown in below table 3.5.

Table 3.5: Solid / Hazardous waste generation and Disposal

S. No Name of the

Solid & Hazardous Waste Quantity

Disposal Method

1 Organic waste (Process Residue)

1550 Kg/Day Sent to Cement Industries

2 Spent Carbon 160 Kg/Day Sent to Cement Industries

3 Solvent Distillation Residue 1034 Kg/Day Sent to Cement Industries

4 Inorganic Waste 1215 Kg/Day Sent to TSDF

5 Spent Mixed Solvents 2303 Kg/Day Sent to authorized recyclers/Cement Industries

6 ETP Sludge 500 Kg/Day Sent to TSDF

7 MEE Salts 4387 Kg/Day Sent to TSDF

8 Organic Evaporative Liquid ( from MEE Stripper)

0.75 KLD Sent to Cement Industry

9 Used Oils 500 L/Annum SPCB Authorized Agencies for Reprocessing/Recycling

10 Detoxified Containers 600 No’s / Month After Detoxification sent to


Page 14

S. No Name of the

Solid & Hazardous Waste Quantity

Disposal Method

outside agencies.

11 Used Lead Acid Batteries 4 No’s/ Annum Send back to suppliers for buyback of New Batteries

12

Ash from boiler Ash from boilers (Existing: 6.0 TPH Coal fired/ Agro waste fired Boiler, Thermo pack Boiler 2,00,000 kcal / hr. and Proposed: 4.0 TPH Coal fired/ Agro waste fired Boiler)

11550 Kg/Day Sent to Brick Manufacturers

3.6 Schematic representations of the feasibility drawing which give

information of EIA purpose.

The applicability of the S.O.1533 for the proposed project was explored by

considering different possibilities & provision made in the said notification.

Considering the products & project location of the proposed project it is noticed that

the proposed project falls under Category 5 (f) “A” of the Schedule-I of EIA

Notification S. O. 1533

As per the provision of the SO 1533, it is necessary to get Environmental Clearance

by applying to MoEF&CC along with the Environmental Impacts Assessment Study

Report for the proposed project prior to commissioning of the project activities.

Therefore the EIA is required to conduct to comply with provisions of SO 1533 made

for Category 5 (f) “A” of schedule –I of the notification.

4.0. Site Analysis

4.1 Connectivity


Ltd) located at Survey No: 32, Tupakulagudem (V) Tallapudi (M), West Godavari

(Dist.), Andhra Pradesh.

Gopavaram village is at a distance of 1.43 KMs in N Direction from the site.

Kovvur is a Town; it is at a distance of 20 KMs in SE side from the project site.

Site is at a distance of 24 KMs from Rajahmundry in SE direction.


Page 15

Nearest State Highway from the site is SH-42 (Koyyalagudem- Nallajerla) at a

distance of 17 KMs in W side from the project site.

Nearest National Highway from the site is NH-5 (Rajahmundry - Anakapalle) at a

distance of 26 KMs in SE side from the project site.

4.2 Land Form, Land use and Land ownership.

The land use of the Area of 10.35 Acres (41885 Sq.m) will be permanently changed

to industrial purpose.

4.3 Existing Infrastructure.

The Proposed project proposed to Expansion of existing Bulk Drug and

Intermediates Manufacturing Unit which is 26 kms away from NH-17 and Mandal

head quarter Tallapudi is 8.50 kms (ESE) from the project site.

4.4 Soil classification

The predominant soils in the district are Sandy loams, black cotton soils and coastal

sands.

4.5 Climatic data from secondary sources.

Annual Max Temp is 36.8.0C

Annual Min Temp is 19.50C

Normal Annual Rainfall is 1078 mm

4.6 Social Infrastructure available.

Well developed social infrastructure facilities are available at nearby Habitations.

5.0 Planning Brief

Proposed plant activities will be started after getting statutory clearance form related

authorities. The project will be completed within two years. Further project

management will take care of all the rules and regulation of statutory authority and

provide all necessary control measures

6.0 Proposed Infrastructure


Page 16

6.1 Industrial Area

The infrastructure and other facilities are already well developed in Tallapudi, which

is a Mandal head quarter.

6.2 Residential Area

The employees who will work in the industry are from nearby villages and hence no

proposal for residential area for employees.

6.3 Green Belt:

14867 SQM (35.50 %) of Green Belt will be developed and maintained.

6.4 Social Infrastructure:

Facilities like roads, communication, Banks, ATM's and medical facilities are

available.

Amenities:

Education Schools including middle, secondary and higher secondary schools, social

welfare hostels

Medical and Health Community Health Centre & Primary Health center are

available in Tallapudi which is 8.50 kms ESE of proposed project site.

Power and water- All the villages are electrified and drinking water facilities are

extended to all villages.

Rail and Road- The project site is very well connected by road through National

Highway No. 16 and nearest railway station is Kovvur.

6.5 Water management

Water requirement will be met through ground water.

6.6 Sewerage System

There will be no discharge of industrial effluent as company proposing Zero Liquid

Discharge (ZLD) system. The treated effluent will be reused.

6.7 Industrial Waste Management

Due to proposed project, the effluent from cooling and Plant/Equipment washing will

be generated and treated in the well designed Effluent Treatment Plant. The treated


Page 17

effluent will be reused.

7.0 Rehabilitation and Resettlement (R & R) Plan

Rehabilitation & Resettlement (R & R) plan is not applicable to this proposed project.

8.0 Project Schedule & Cost Estimates

Proposed project activities will be started after getting statutory clearance form

related authorities. The project will be completed within two years.

The project cost for proposed Project is 3900 Lakhs (39 Crores) will be used for

constructing additional building, Equipments & misc.

9.0 Analysis of Benefits to proposal

Local people will get direct financial benefit by way of employment.

Local people will get some contracts of supply and services to get indirect

income.

Company will contribute in improving education and health facilities in nearby

area.

tagoor chemicals private limitedenvironmentclearance.nic.in/writereaddata/online/tor/07...raju is...

Documents